Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS)’s stock price hit a new 52-week high during trading on Tuesday . The stock traded as high as $4.40 and last traded at $4.28, with a volume of 794428 shares. The stock had previously closed at $4.28.
CVRS has been the topic of several analyst reports. Cowen lowered Corindus Vascular Robotics from an “outperform” rating to a “market perform” rating and upped their target price for the stock from $4.00 to $4.28 in a report on Thursday, August 8th. Zacks Investment Research lowered Corindus Vascular Robotics from a “hold” rating to a “sell” rating in a report on Tuesday, August 13th.
Corindus Vascular Robotics (NYSEAMERICAN:CVRS) last announced its quarterly earnings data on Thursday, August 8th. The medical equipment provider reported ($0.06) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.05) by ($0.01). The firm had revenue of $4.58 million during the quarter, compared to the consensus estimate of $4.10 million.
About Corindus Vascular Robotics (NYSEAMERICAN:CVRS)
Corindus Vascular Robotics, Inc designs, manufactures, and sells robotic-assisted systems for use in interventional vascular procedures in the United States and internationally. The company offers CorPath system, a medical device with robotic-assisted precision for coronary and peripheral interventional procedures.
Further Reading: Which market index is the best?
Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.